摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

5-甲基-2-硝基苯甲醚 | 38512-82-2

中文名称
5-甲基-2-硝基苯甲醚
中文别名
5-甲基-2-硝基茴香醚;甲基-2-硝基茴香醚;2-硝基-5-甲基苯甲醚
英文名称
3-methoxy-4-nitrotoluene
英文别名
5-methyl-2-nitroanisol;5-methyl-2-nitroanisole;2-methoxy-4-methyl-1-nitrobenzene;2-methoxy-4-methylnitrobenzene
5-甲基-2-硝基苯甲醚化学式
CAS
38512-82-2
化学式
C8H9NO3
mdl
MFCD00007367
分子量
167.164
InChiKey
XCOUVPWGTSKINY-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    58-60 °C(lit.)
  • 沸点:
    153 °C(Press: 12 Torr)
  • 密度:
    1.180±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    2.1
  • 重原子数:
    12
  • 可旋转键数:
    1
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.25
  • 拓扑面积:
    55
  • 氢给体数:
    0
  • 氢受体数:
    3

安全信息

  • 危险品标志:
    Xn,Xi
  • 安全说明:
    S26,S36
  • 危险类别码:
    R22
  • WGK Germany:
    3
  • 海关编码:
    2909309090
  • 危险性防范说明:
    P305+P351+P338
  • 危险性描述:
    H302,H319
  • 储存条件:
    室温且干燥

SDS

SDS:a3d011acbd8ff9ae4d4146f60126f3db
查看
Material Safety Data Sheet

Section 1. Identification of the substance
Product Name: 5-Methyl-2-nitroanisole
Synonyms: 3-Methoxy-4-nitrotoluene; 2-methoxy-4-methyl-1-nitrobenzene

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.
H302: Harmful if swallowed
H319: Causes serious eye irritation
P305+P351+P338: IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses if present
and easy to do – continue rinsing

Section 3. Composition/information on ingredients.
Ingredient name: 5-Methyl-2-nitroanisole
CAS number: 38512-82-2

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
Eye contact:
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Storage: Store in closed vessels.

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
Melting point: No data
Flash point: No data
Density: No data
Molecular formula: C8H9NO3
Molecular weight: 167.2

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides.

Section 11. Toxicological information
No data.

Section 12. Ecological information
No data.

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

Section 14. Transportation information
Non-harzardous for air and ground transportation.

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.


SECTION 16 - ADDITIONAL INFORMATION
N/A

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量
    • 1
    • 2
    • 3

反应信息

点击查看最新优质反应信息

文献信息

  • Substituted Isoquinolinones and Quinazolinones
    申请人:BERGHAUSEN Joerg
    公开号:US20110230457A1
    公开(公告)日:2011-09-22
    The invention relates to substituted nitrogen containing bicyclic heterocycles of the formula (I) wherein Z is CH 2 or N—R 4 and X, R 1 , R 2 , R 4 , R 6 , R 7 and n are as defined in the description. Such compounds are suitable for the treatment of a disorder or disease which is mediated by the activity of MDM2 and/or MDM4, or variants thereof.
    这项发明涉及公式(I)中的取代氮含有的双环杂环化合物,其中Z为CH2或N—R4,X、R1、R2、R4、R6、R7和n的定义如描述中所述。这类化合物适用于治疗由MDM2和/或MDM4的活性介导的疾病或疾病变体。
  • [EN] SUBSTITUTED BENZOTHIENYL - PYRROLOTRIAZINES AND USES THEREOF IN THE TREATMENT CANCER<br/>[FR] BENZOTHIÉNYL - PYRROLOTRIAZINES SUBSTITUÉES ET UTILISATIONS DE CELLES-CI POUR LE TRAITEMENT DU CANCER
    申请人:BAYER IP GMBH
    公开号:WO2013087647A1
    公开(公告)日:2013-06-20
    This invention relates to novel substituted 5-(l-benzothiophen-2-yl)pyrrolo[2,l-fJ[l,2,4]triazin-4-amine derivatives having protein tyrosine kinase inhibitory activities, to processes for the preparation of such compounds, to pharmaceutical compositions containing such compounds, and to the use of such compounds or compositions for treating proliferative disorders, in particular cancer and tumor diseases.
    这项发明涉及新型的取代5-(1-苯并噻吩-2-基)吡咯并[2,1-f][1,2,4]三嗪-4-胺衍生物,具有蛋白酪氨酸激酶抑制活性,以及制备这类化合物的方法,含有这类化合物的药物组合物,以及利用这类化合物或组合物治疗增殖性疾病,特别是癌症和肿瘤疾病。
  • Azabenzocycloheptenones. Part IX. A new synthesis and some reactions of the 5,6-dihydrodibenz[b,e]azepin-11-one system
    作者:I. MacDonald、G. R. Proctor
    DOI:10.1039/j39690001321
    日期:——
    N-(m-methoxybenzyl)-N-tosylanthraniloyl chloride with aluminium chloride at –20° yielded 5,6-dihydro-8-methoxy-5-tosyldibenz[b,e]azepine-11-one (70%), which could be detosylated with polyphosphoric acid. Some reactions of the dihydrodibenzazepinone system are described.
    环化ñ - (米甲氧基苄基) - ñ -tosylanthraniloyl酰化铝在-20℃,得到5,6-二氢-8-甲氧基-5- tosyldibenz [ B,E ]氮杂-11-酮(70%),可以用多磷酸去甲苯磺酸化。描述了二氢二苯并ze庚酮系统的一些反应。
  • Interaction between electron donor and acceptor groups in some trisubstituted benzenes. Part 1. Relative reactivities of 4-substituted 1,2-dinitrobenzenes towards sodium methoxide
    作者:Sampatrao D. Patil、P. Madhavan Nair
    DOI:10.1039/p29880000637
    日期:——
    on the properties of some 1,2,4-trisubstituted benzenes, the rates of reaction of a series of four 4-substituted 1,2-dinitrobenzenes with sodium methoxide in methanol have been studied. Although reactivities at the 2-position were qualitatively in the order to be expected from inductive effects, those at the 1-position were highly sensitive to the influence of mesomeric donor action of the 4-substituent
    为了研究“通过共轭”对某些1,2,4-三取代苯的性质的影响,已经确定了一系列四个4-取代的1,2-二硝基苯甲醇钠甲醇中的反应速率。研究过。尽管在2位反应性的定性顺序是从诱导效应中预期的,但在1位反应性对4取代基的介晶供体作用的影响高度敏感。对于4-烷基衍生物,观察到相对较大的影响。C–H高共轭似乎比C–C高共轭强。
  • Controlling the Course of a Two-Way Switchable Pd-Catalyzed Process by means of Empirical Multivariate Models
    作者:Alexander H. Sandtorv、Hans-René Bjørsvik
    DOI:10.1002/cctc.201500234
    日期:2015.7.13
    two‐way switchable Pd‐catalyzed process that can pursue two different mechanisms, namely hydro‐ and methoxy‐deiodination was discovered, developed, and optimized by means of statistical experimental design, multivariate modelling, and response surface methodology. The investigation revealed that the two‐way switchable process might be controlled either by ligand alone, or by ligand and other process variables
    通过统计实验设计,多变量建模和响应面方法,发现,开发和优化了一种可双向转换的Pd催化过程,该过程可遵循两种不同的机理,即加氢和甲氧基脱。研究表明,双向可切换过程既可以单独由配体控制,也可以由配体和其他过程变量组合控制。本研究代表了一个催化系统的第一个例子,该催化系统可以通过简单地调整实验变量来选择性地提供加氢或甲氧基脱作用。
查看更多

表征谱图

  • 氢谱
    1HNMR
  • 质谱
    MS
  • 碳谱
    13CNMR
  • 红外
    IR
  • 拉曼
    Raman
查看更多图谱数据,请前往“摩熵化学”平台
查看更多图谱数据,请前往“摩熵化学”平台
cnmr
查看更多图谱数据,请前往“摩熵化学”平台
查看更多图谱数据,请前往“摩熵化学”平台
  • 峰位数据
  • 峰位匹配
  • 表征信息
Shift(ppm)
Intensity
查看更多图谱数据,请前往“摩熵化学”平台
Assign
Shift(ppm)
查看更多图谱数据,请前往“摩熵化学”平台
测试频率
样品用量
溶剂
溶剂用量
查看更多图谱数据,请前往“摩熵化学”平台

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S,S)-邻甲苯基-DIPAMP (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(-)-4,12-双(二苯基膦基)[2.2]对环芳烷(1,5环辛二烯)铑(I)四氟硼酸盐 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(4-叔丁基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(3-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-4,7-双(3,5-二-叔丁基苯基)膦基-7“-[(吡啶-2-基甲基)氨基]-2,2”,3,3'-四氢1,1'-螺二茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (R)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4S,4''S)-2,2''-亚环戊基双[4,5-二氢-4-(苯甲基)恶唑] (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (3aR,6aS)-5-氧代六氢环戊基[c]吡咯-2(1H)-羧酸酯 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[((1S,2S)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1S,2S,3R,5R)-2-(苄氧基)甲基-6-氧杂双环[3.1.0]己-3-醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (1-(2,6-二氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙蒿油 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫-d6 龙胆紫